LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases

Antimicrobial peptides (AMPs), as well as host defense peptides (HDPs), constitute the first line of defense as part of the innate immune system. Humans are known to express antimicrobial precursor proteins, which are further processed to generate AMPs, including several types of α/β defensins, hist...

Full description

Bibliographic Details
Main Authors: Surajit Bhattacharjya, Zhizhuo Zhang, Ayyalusamy Ramamoorthy
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/14/3/320
_version_ 1797241856040370176
author Surajit Bhattacharjya
Zhizhuo Zhang
Ayyalusamy Ramamoorthy
author_facet Surajit Bhattacharjya
Zhizhuo Zhang
Ayyalusamy Ramamoorthy
author_sort Surajit Bhattacharjya
collection DOAJ
description Antimicrobial peptides (AMPs), as well as host defense peptides (HDPs), constitute the first line of defense as part of the innate immune system. Humans are known to express antimicrobial precursor proteins, which are further processed to generate AMPs, including several types of α/β defensins, histatins, and cathelicidin-derived AMPs like LL37. The broad-spectrum activity of AMPs is crucial to defend against infections caused by pathogenic bacteria, viruses, fungi, and parasites. The emergence of multi-drug resistant pathogenic bacteria is of global concern for public health. The prospects of targeting antibiotic-resistant strains of bacteria with AMPs are of high significance for developing new generations of antimicrobial agents. The 37-residue long LL37, the only cathelicidin family of AMP in humans, has been the major focus for the past few decades of research. The host defense activity of LL37 is likely underscored by its expression throughout the body, spanning from the epithelial cells of various organs—testis, skin, respiratory tract, and gastrointestinal tract—to immune cells. Remarkably, apart from canonical direct killing of pathogenic organisms, LL37 exerts several other host defense activities, including inflammatory response modulation, chemo-attraction, and wound healing and closure at the infected sites. In addition, LL37 and its derived peptides are bestowed with anti-cancer and anti-amyloidogenic properties. In this review article, we aim to develop integrative, mechanistic insight into LL37 and its derived peptides, based on the known biophysical, structural, and functional studies in recent years. We believe that this review will pave the way for future research on the structures, biochemical and biophysical properties, and design of novel LL37-based molecules.
first_indexed 2024-04-24T18:29:58Z
format Article
id doaj.art-461004323080430daa86aada4d2726b9
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-04-24T18:29:58Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-461004323080430daa86aada4d2726b92024-03-27T13:27:57ZengMDPI AGBiomolecules2218-273X2024-03-0114332010.3390/biom14030320LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related DiseasesSurajit Bhattacharjya0Zhizhuo Zhang1Ayyalusamy Ramamoorthy2School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, SingaporeDepartment of Chemistry, Biomedical Engineering, Macromolecular Science and Engineering, Michigan Neuroscience Institute, The University of Michigan, Ann Arbor, MI 48109, USADepartment of Chemistry, Biomedical Engineering, Macromolecular Science and Engineering, Michigan Neuroscience Institute, The University of Michigan, Ann Arbor, MI 48109, USAAntimicrobial peptides (AMPs), as well as host defense peptides (HDPs), constitute the first line of defense as part of the innate immune system. Humans are known to express antimicrobial precursor proteins, which are further processed to generate AMPs, including several types of α/β defensins, histatins, and cathelicidin-derived AMPs like LL37. The broad-spectrum activity of AMPs is crucial to defend against infections caused by pathogenic bacteria, viruses, fungi, and parasites. The emergence of multi-drug resistant pathogenic bacteria is of global concern for public health. The prospects of targeting antibiotic-resistant strains of bacteria with AMPs are of high significance for developing new generations of antimicrobial agents. The 37-residue long LL37, the only cathelicidin family of AMP in humans, has been the major focus for the past few decades of research. The host defense activity of LL37 is likely underscored by its expression throughout the body, spanning from the epithelial cells of various organs—testis, skin, respiratory tract, and gastrointestinal tract—to immune cells. Remarkably, apart from canonical direct killing of pathogenic organisms, LL37 exerts several other host defense activities, including inflammatory response modulation, chemo-attraction, and wound healing and closure at the infected sites. In addition, LL37 and its derived peptides are bestowed with anti-cancer and anti-amyloidogenic properties. In this review article, we aim to develop integrative, mechanistic insight into LL37 and its derived peptides, based on the known biophysical, structural, and functional studies in recent years. We believe that this review will pave the way for future research on the structures, biochemical and biophysical properties, and design of novel LL37-based molecules.https://www.mdpi.com/2218-273X/14/3/320antimicrobial peptideshost defense peptidesLL37structurebiophysicalhuman antimicrobial peptides
spellingShingle Surajit Bhattacharjya
Zhizhuo Zhang
Ayyalusamy Ramamoorthy
LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases
Biomolecules
antimicrobial peptides
host defense peptides
LL37
structure
biophysical
human antimicrobial peptides
title LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases
title_full LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases
title_fullStr LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases
title_full_unstemmed LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases
title_short LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases
title_sort ll 37 structures antimicrobial activity and influence on amyloid related diseases
topic antimicrobial peptides
host defense peptides
LL37
structure
biophysical
human antimicrobial peptides
url https://www.mdpi.com/2218-273X/14/3/320
work_keys_str_mv AT surajitbhattacharjya ll37structuresantimicrobialactivityandinfluenceonamyloidrelateddiseases
AT zhizhuozhang ll37structuresantimicrobialactivityandinfluenceonamyloidrelateddiseases
AT ayyalusamyramamoorthy ll37structuresantimicrobialactivityandinfluenceonamyloidrelateddiseases